$MGRX Income Statement | Understand Stock

$MGRX

$0.26 +$0.01 (4.07%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Revenues
Revenues
Cost of revenues
Cost of revenues - related party
Gross profit
Operating expenses
General and administrative expenses
Salary and benefits
Advertising and marketing
Investor relations
Stock based compensation
Total operating expenses
Loss from operations
Other income
Other (income) expense
Interest expense
Imputed interest - related party
Amortization of intangible assets
Impairment of license agreement
Loss from settlement
Loss from debt extinguishment - related parties
Total other (income) expense
Loss before income taxes
Net loss
Net loss attributed to non-controlling interest
Net loss attributed to Mangoceuticals, Inc.
Basic and diluted loss per share
Basic loss per share
Diluted loss per share
Weighted average number of shares outstanding
Basic
Diluted
Preferred stock dividend requirements
Net loss attributed to Mangoceuticals, Inc. common stockholders

Comments